Aegis has identified unique markers that are expected to be detected in routinely analyzed human urine. Our goal is to provide clinicians greater insight regarding potential substitution to mitigate risk and make treatment decisions with greater confidence.
The expansion of urine drug monitoring practices has led to more opportunities for individuals to attempt to “beat” a drug test. This has led to a significant increase in the availability of synthetic urine. Manufacturers of synthetic urine have become wise to the measures used to identify substituted specimens.
With non-prescription substance use continuing to contribute to record numbers of fatal and non-fatal overdoses, it is extremely important to utilize expanded specimen validity measures.
Sarah Ramsey, Nurse Practitioner
Unity Health – Clarity Health & Wellness
Searcy, AR